首页> 美国卫生研究院文献>Case Reports in Dermatological Medicine >Reactivation of Cutaneous Leishmaniasis after Renal Transplantation: A Case Report
【2h】

Reactivation of Cutaneous Leishmaniasis after Renal Transplantation: A Case Report

机译:肾移植术后皮肤利什曼病的再激活:一例报告

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A 45-year-old man with reactivation of previously existing and subsiding cutaneous leishmaniasis on his wrist and lower leg (shin) after renal transplantation was admitted to our dermatology service on March 2008. He presented to us with two huge tumoral and cauliflower-like lesions. Skin smear and histopathology of skin showed leishman bodies and confirmed the diagnosis. After renal transplantation, he received cyclosporine plus prednisolone to induce immunosuppression and reduce the probability of transplant rejection. After immunosuppressive therapy, reactivation of cutaneous leishmaniasis with the above presentation took place. The patient responded to 800 mg/day intravenous sodium stibogluconate for 3 weeks plus local cryotherapy. Systemic plus local therapy along with reducing the doses of immunosuppressive drugs led to improvement of lesions. Reactivation of leishmaniasis after immunosuppression has been rarely reported.
机译:一名45岁的男子在肾脏移植后在手腕和小腿上恢复了先前存在的和逐渐消退的皮肤利什曼病,并于2008年3月被收录到我们的皮肤病学服务中。他向我们展示了两个巨大的肿瘤样花椰菜样病变。皮肤涂片检查和皮肤组织病理学检查显示利什曼尸体并证实了诊断。肾移植后,他接受环孢素加泼尼松龙诱导免疫抑制并减少移植排斥的可能性。免疫抑制治疗后,以上述表现恢复皮肤利什曼病。患者对800μmg/ day的stibogluconate静脉滴注钠应答3周,并接受局部冷冻治疗。全身加局部治疗以及减少免疫抑制药物的剂量可改善病灶。免疫抑制后重新激活利什曼病的报道很少。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号